MNPR MONOPAR THERAPEUTICS
Health Care · Russell 2000
Next earnings: Thu 12 Nov 2026 · estimated
What 16 analyst firms say about MONOPAR THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
14 rated views · 16 analyst/firm records · 16 firms
Radar score
- Russell 2000 · Top Picks · 6MGood · #23 in the index90
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8075
Recent analyst activity · last 90 days
Our tracked history has 12 reports on MNPR from 11 analyst firms in the last 90 days (16 firms in the past year).
Comparing each firm's latest target with its previous one: 4 raised their price target, 2 left it unchanged and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Barclays raised its target from $128.00 (set 13 Aug 2026) to $145.00 on 11 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barclays | Etzer Darout | Buy | 11 Sep 2026 | 145.00 USD |
| Brookline Capital Markets | Kemp Dolliver | Buy | 17 Aug 2026 | 124.00 USD |
| BTIG | Jeet Mukherjee | Buy | 12 Aug 2026 | 133.00 USD |
| Cantor Fitzgerald | Kristen Kluska | Hold | 13 Aug 2026 | 119.00 USD |
| Chardan Capital Markets | Keay Nakae | Buy | 30 Mar 2026 | 100.00 USD |
| H.C. Wainwright | Andres Y Maldonado | Buy | 22 Sep 2026 | 125.00 USD |
| Jonestrading | Justin Walsh | Buy | 1 Jul 2026 | 130.00 USD |
| Lake Street Capital Markets | Chad Messer | Buy | 30 Jun 2026 | 103.00 USD |
| Leerink Partners | Joseph P Schwartz | Buy | 12 Aug 2026 | 145.00 USD |
| Lucid Capital Markets | Elemer Piros | Buy | 30 Jun 2026 | 130.00 USD |
| Morgan Stanley | Unnamed analyst | Buy | 17 Aug 2026 | 130.00 USD |
| Piper Sandler | Biren Amin | Buy | 27 Sep 2026 | — |
| Raymond James | Christopher Raymond | Buy | 12 Aug 2026 | 123.00 USD |
| UBS | Unnamed analyst | — | 23 Jul 2026 | 125.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 13 Aug 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:29 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.